Today’s top gainers include the company Mylan N.V. (NASDAQ:MYL) which is in the industry Drugs – Generic, gaining 1.58% today. In the last week its performance is 2.62%, and -6.87% for the past quarter. Currently, Mylan N.V., MYL has a target price of 56.71, so today’s gain of 1.58% is a significant step towards its target price. The GAP today is therefore -0.51%.
Mylan N.V. (NASDAQ:MYL), has a market cap of 22257.14, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 64.50%.
At the current price of 41.91, it has a dividend yield of *TBA, and its target price is 56.71. This is with a profit margin of 8.10%, and total debt/equity of 1.31. Mylan N.V. (NASDAQ:MYL) has a P/E of 26.64, as well as a forward P/E of 7.27.
With a current EPS of 1.57, and a forecasted EPS growth for next year at 16.34%,Mylan N.V. (NASDAQ:MYL) has had a EPS growth for the past five years at 20.20%. For the next five years EPS growth is projected to be 13.26%.
Performance for the year is -10.16%. Since its IPO date on 12/18/1987, the total performance to date is -22.49%.
Volume today for Mylan N.V. (NASDAQ:MYL), is 4146600, while its average volume is 5655.8. Whilst the total gain today was 1.58%, it did have a day high of -16.85%.
Volatility for this week has been at 2.30%, and 3.19% for the month. The 52-week low for Mylan N.V., MYL has been 11.49%, while the 52-week-high has reached -24.50%.
Looking at its return of investments, which is 8.20%, and its return on assets is 3.40%. Mylan N.V. (NASDAQ:MYL) has an operating margin of 15.70%. With a sales growth of 8.00% quarter over quarter. Bearing in mind that Mylan N.V., MYL is in the sector Healthcare, its long-term debt/equity is 1.24, and has a current ratio of 3.2 and 2.6 for quick ratio.
So what is the value of Mylan N.V.? Well its PEG is 2.01, and the P/S is 2.24, along with a P/B of 2.05. Meanwhile it has a p/cash of 3.5.